DCS Innovative Diagnostik-Systeme Dr. Christian Sartori
DCS Innovative Diagnostik-Systeme Dr. Christian Sartori GmbH & Co. KG
About DCS Innovative Diagnostik-Systeme Dr. Christian Sartori
We, DCS Innovative Diagnostic Systems, see ourselves as a partner for pathology in research and routine. We are specialists in the field of structural and functional detection in cells with the aim to identify physiological and pathophysiological conditions on the molecular level. Since our foundation in 1992 more and more customers are convinced by our products and concepts. DCS products for immunohistochemistry, including primary antibodies, highly sensitive detection systems and chromogens, are now present in most pathologies in Germany.
In addition to our own products, we distribute reagents from selected international cooperation partners.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Industry : Diagnostics
Product portfolio of DCS Innovative Diagnostik-Systeme Dr. Christian Sartori
Similar companies
Here you will find DCS Innovative Diagnostik-Systeme Dr. Christian Sartori GmbH & Co. KG
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
